Families across the United States are facing substance use patterns that are more unpredictable and dangerous than ever. Alongside fentanyl, a powerful illicit opioid, another substance called xylazine is appearing more often in communities.
This combination raises overdose risk and brings serious health concerns that many families may not expect. When families understand how xylazine interacts with fentanyl and what symptoms signal immediate risk, they are better prepared to take action when every moment matters.
Spokane Falls Recovery Center provides evidence-based addiction treatment programs to the Spokane, Washington, area that support individuals and families affected by substance use, including fentanyl and other emerging risks. Through compassionate care and proven approaches, Spokane Falls Recovery Center helps families find clarity, stability, and a path forward.
What are xylazine and fentanyl?
Xylazine is a medication originally developed for veterinary use. It is a sedative approved for animals, not for humans. In animal care, xylazine is used to calm large animals by slowing the central nervous system and lowering heart rate and blood pressure. Its common street name is “tranq.”
Fentanyl is a synthetic opioid that is much stronger than heroin or morphine. It is commonly found in today’s illicit drug supply and plays a major role in overdose deaths across the U.S. Even very small amounts can slow breathing, which can quickly lead to a life-threatening overdose.
While these substances were created for very different purposes, they are now often found together in the illicit drug supply. Xylazine can be frequently added without a person’s knowledge, which makes substance use far more unpredictable. This growing trend has increased the risk of drug-related harm and has contributed to a rising number of overdose deaths that may be linked to this unexpected and dangerous drug combination. The U.S. Drug Enforcement Administration (DEA) has issued a warning to the public about how xylazine is making the deadliest drug threat the country has ever faced, fentanyl, even deadlier.
The dangers of mixing xylazine with fentanyl
Research funded by the National Institute on Drug Abuse (NIDA) has helped shed light on how xylazine affects opioid overdoses. One study found that people with both xylazine and fentanyl in their systems at the time of overdose were not more likely to die than those who overdosed on opioids alone. The study also showed no higher rates of heart attack, coma, hospital admission, or longer hospital stays among people exposed to xylazine alongside opioids.
Even with these findings, mixing xylazine with fentanyl remains extremely dangerous. Both substances slow the body’s vital systems, including breathing, heart rate, and blood pressure. Together, they place added strain on the heart, lungs, and brain, which can make overdoses more complex, harder to recognize, and more difficult to respond to safely.
Key dangers linked to xylazine and fentanyl use can include:
- Dangerously low blood pressure
- Slow or difficult breathing
- Loss of consciousness
- Increased risk of overdose complications
- Severe skin ulcers and necrotic wounds
Xylazine use has also been linked to serious skin damage that can develop even when the substance is not injected into the affected area. These wounds can worsen quickly, become infected, and are often difficult to treat. In many cases, people are unaware that xylazine is present until severe complications appear.
Although data collection is still evolving, public health officials have identified xylazine in a growing number of fatal overdose cases involving fentanyl. This trend highlights the ongoing risks of unpredictable substance exposure and the importance of early intervention, medical care, and evidence-based addiction treatment.
How xylazine is changing the overdose landscape
The overdose crisis is evolving as the illicit drug market changes. Xylazine has altered overdose patterns by adding risks that go beyond opioids alone. Because xylazine is not an opioid, it does not respond to standard opioid reversal methods.
Overdose involving xylazine often presents differently from a typical opioid overdose. While fentanyl overdose deaths are usually tied to slowed breathing, xylazine can cause prolonged sedation, dangerously low blood pressure, and serious wounds. These effects can continue even after opioid symptoms improve.
Xylazine also complicates toxicology testing after death. It is not always included in routine postmortem tests, which makes tracking overdose deaths more difficult. This could result in drug overdose deaths linked to xylazine being underreported, delaying public health responses and community awareness.
What to look for: Signs and symptoms
Recognizing the signs of a possible xylazine and fentanyl overdose can help families respond quickly. Symptoms may appear similar to opioid overdose at first, but there are important differences.
Common warning signs of a xylazine and fentanyl overdose may include:
- Difficulty breathing or slow breathing
- Dangerously low blood pressure
- Loss of consciousness or extreme sedation
- Pale or bluish skin
- Severe wounds or skin ulcers that worsen over time
Unlike typical opioid overdoses, people exposed to xylazine may remain unresponsive even after breathing improves. The presence of severe wounds or unexplained skin damage is another red flag that xylazine may be involved.
Families who notice these signs should treat the situation as a medical emergency and call 911 immediately. Sudden changes in behavior, extreme sedation, or the presence of physical wounds should never be ignored, as quick action can save a life.
What families should do if they suspect use
If a family member may be using drugs that contain xylazine and fentanyl, quick and informed action is critical. Overdose response still saves lives, even when outcomes are uncertain.
Steps families should take include:
- Call emergency services immediately if overdose symptoms appear
- Administer naloxone if available, understanding it may not reverse xylazine effects
- Stay with the person until help arrives
- Seek guidance from harm reduction services or treatment professionals
Naloxone remains important because it can reverse fentanyl-related breathing suppression. However, it does not address xylazine’s effects on blood pressure or sedation. This is why emergency care is needed.
Families should also watch for ongoing signs of drug use, such as unexplained wounds, extreme fatigue, or changes in mood and behavior. Early intervention and professional support can help reduce long-term harm.
Treatment and recovery options
Treating substance use disorders involving xylazine and fentanyl requires careful, evidence-based care. Because xylazine adds unique medical risks, professional detox and treatment are strongly recommended.
Effective treatment options often include:
- Medical detoxification with close monitoring
- Behavioral therapy to address substance use patterns
- Long-term support for recovery and relapse prevention
- Coordination with harm reduction services when appropriate
Xylazine withdrawal can present challenges such as agitation, blood pressure changes, and prolonged discomfort. Specialized care helps manage these symptoms safely while preparing individuals for continued treatment.
Families are encouraged to consult with experienced providers. Spokane Falls Recovery Center offers guidance and addiction treatment services to support individuals affected by complex substance use patterns.
The importance of local awareness and response in Spokane
Local awareness plays a critical role in reducing overdose deaths. Spokane has not been immune to the changing illicit drug supply, and staying informed about local overdose trends and risks can help families and professionals respond more effectively.
Public health efforts in the region focus on education, prevention, and rapid response. Drug seizure reports and public alerts help track emerging substances like xylazine. Collaboration between local agencies and national drug control policy efforts supports broader prevention strategies.
Community education, early intervention, and access to treatment services remain key to managing the overdose crisis in Spokane. A coordinated local response can help reduce harm and save lives.
FAQs on xylazine and fentanyl overdose
Xylazine is a veterinary tranquilizer that has entered the illicit drug supply, often mixed with fentanyl to extend or alter drug effects, increasing overdose risk.
Fentanyl is an opioid that slows breathing, while xylazine depresses the central nervous system and lowers blood pressure, creating additional dangers.
Call emergency services immediately and administer naloxone if available, while understanding it may not address all symptoms.
Yes. Evidence-based treatment centers in the Spokane area, like Spokane Falls Recovery Center, provide integrated care for individuals affected by multiple substances.
Staying informed and taking action
The combination of xylazine and fentanyl has introduced new and serious overdose risks. Understanding how these substances interact, recognizing warning signs, and knowing how to respond can help families protect their loved ones. Drug overdose deaths continue to rise, but education, awareness, and access to evidence-based addiction treatment can make a difference.
Families and community members are encouraged to stay informed and seek support early. Spokane Falls Recovery Center is available to help individuals and families navigate addiction treatment options and take meaningful steps toward safety and recovery. Call 844.962.2775 to reach out to our admissions team, or complete our contact form, and a team member will respond as soon as possible.
